Appendix B
Workshop Speakers

Jeff Abrams, National Cancer Institute

Laurence Baker, Southwest Oncology Group and the University of Michigan

Al Benson,, Robert H. Lurie Comprehensive Cancer Center

Gordon Bernard, Vanderbilt University

Jan Buckner, Mayo Clinic

Robert Califf, Duke University

Michael Caligiuri,, Ohio State University Comprehensive Cancer Center

Renzo Canetta,, Bristol–Myers Squibb

Deborah Collyar, Patient Advocates in Research

Robert Comis, Coalition of National Cancer Cooperative Groups

Walter Curran, Winship Cancer Institute

David Dilts, Vanderbilt University

James Doroshow, National Institutes of Health

John Feldmann, Moses Cone Regional Cancer Center

Leslye Fitterman, Centers for Medicare and Medicaid Services

Gwendolyn Fyfe, Genentech

Stephen Grubbs, Christiana Care Community Clinical Oncology Program

Richard Kaplan, National Cancer Research Network in the United Kingdom

Alan Keller, US Oncology, Cancer Care Associates

Allen Lichter, American Society of Clinical Oncology

Maurie Markman, M. D. Anderson Comprehensive Cancer Center



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 117
Appendix B Workshop Speakers Jeff Abrams, National Cancer Institute Laurence Baker, Southwest Oncology Group and the University of Michigan Al Benson, Robert H. Lurie Comprehensive Cancer Center , Gordon Bernard, Vanderbilt University Jan Buckner, Mayo Clinic Robert Califf, Duke University Michael Caligiuri, Ohio State University Comprehensive Cancer Center , Renzo Canetta, Bristol–Myers Squibb , Deborah Collyar, Patient Advocates in Research Robert Comis, Coalition of National Cancer Cooperative Groups Walter Curran, Winship Cancer Institute David Dilts, Vanderbilt University James Doroshow, National Institutes of Health John Feldmann, Moses Cone Regional Cancer Center Leslye Fitterman, Centers for Medicare and Medicaid Services Gwendolyn Fyfe, Genentech Stephen Grubbs, Christiana Care Community Clinical Oncology Program Richard Kaplan, National Cancer Research Network in the United Kingdom Alan Keller, US Oncology, Cancer Care Associates Allen Lichter, American Society of Clinical Oncology Maurie Markman, M. D. Anderson Comprehensive Cancer Center 

OCR for page 117
 MULTI-CENTER PHASE III CLINICAL TRIALS Lee Newcomer, UnitedHealthcare John Niederhuber, National Cancer Institute Richard Pazdur, Food and Drug Administration , Richard Schilsky, University of Chicago Marcy Waldinger, University of Michigan Comprehensive Cancer Center